Cytrellis Biosystems, Inc. recalls Cytrellis ellacor System with Micro-Coring Technology-Dermal Micro-Coring System System intended for the treatment of mo

Recalled June 7, 2023 · FDA recall Z-1648-2023 · Cytrellis Biosystems

Hazard

Irregular core patterns could cause potential overlap of cores at the 8% setting, potentially leading to prolonged healing, irregularities in patient skin texture post-treatment, and/or scarring. · FDA Class II

Units

89 units

Sold at

Nationwide

Description

Irregular core patterns could cause potential overlap of cores at the 8% setting, potentially leading to prolonged healing, irregularities in patient skin texture post-treatment, and/or scarring.

Product

Cytrellis ellacor System with Micro-Coring Technology-Dermal Micro-Coring System System intended for the treatment of moderate and severe wrinkles in the mid and lower face. Model #: Gen 4

Manufacturer(s)

Cytrellis Biosystems, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →